Cleared Traditional

K042999 - CARTO XP EP NAVIGATION SYSTEM, SOFTWARE VERISON 8

K042999 is an FDA 510(k) clearance for CARTO XP EP NAVIGATION SYSTEM, manufactured by Biosense Webster, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 140-day FDA review.

K042999 · Biosense Webster, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2005
Decision
140d
Days
Class 2
Risk

K042999 is an FDA 510(k) clearance for the CARTO XP EP NAVIGATION SYSTEM, SOFTWARE VERISON 8. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Biosense Webster, Inc. (Diamond Bar, US). The FDA issued a Cleared decision on March 21, 2005 after a review of 140 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biosense Webster, Inc. devices

FDA 510(k) Submission Details - K042999

510(k) Number K042999 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 01, 2004
Decision Date March 21, 2005
Days to Decision 140 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
15d slower than avg
Panel avg: 125d · This submission: 140d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 359
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K042999.
LIFESHIRT REAL-TIME WITH VIVOMONITOR SOFTWARE
K043604 · Vivometrics, Inc. · Apr 2005
HEARTWAVE II CARDIAC DIAGNOSTIC SYSTEM
K050225 · Cambridge Heart, Inc. · Apr 2005
MUSE CARDIOLOGY INFORMATION SYSTEM
K050614 · Ge Medical Systems Information Technologies · Apr 2005
HORIZON ANGIO CATHLAB
K043564 · Mennen Medical , Ltd. · Jan 2005
MODIFICATION TO: RADIANALYZER, MODEL 12711
K042628 · Radi Medical Systems AB · Jan 2005
CARDIO SPECTRUM DIAGNOSTIC SYSTEM (CSD)
K042849 · Cardiobiomedical Corporation · Jan 2005